Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Middle Class Tax (AMT) Relief Act of 2007
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR 3590: PATIENT PROTECTION AND AFFORDABLE CARE ACT; PROVISIONS RELATED TO BIO SIMILARS, FEES AND TAXES
American Middle Class Tax (AMT) Relief Act of 2007
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR 3590: PATIENT PROTECTION AND AFFORDABLE CARE ACT; PROVISIONS RELATED TO BIO SIMILARS, FEES AND TAXES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALLERGAN, INC. via ALLERGAN, INC.
2015 · first_quarter · 1T
GENERAL DISCUSSIONS RELATED TO THE SECURITIES AND EXCHANGE COMMISSION'S POLICIES ON FRAUD/INSIDER TRADING
GENERAL ISSUES RELATED TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN, INC.
Source: Senate LDA
America's Affordable Health Choices Act of 2009
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR 3200/S.1796: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009/AMERICA'S HEALTHY FUTURE ACT OF 2009; ISSUES RELATED TO FOLLOW-ON BIOLOGICS, BIOSIMILARS, COSMETIC TAX GENERAL DISCUSSIONS REGARDING ISSUES REALTED TO LUMIGAN AND LATISSE
America's Affordable Health Choices Act of 2009
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; ISSUES RELATED TO FOLLOW-ON BIOLOGICS
America's Affordable Health Choices Act of 2009
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; ISSUES RELATED TO FOLLOW-ON BIOLOGICS
HR 3200/S.1796: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009/AMERICA'S HEALTHY FUTURE ACT OF 2009; ISSUES RELATED TO FOLLOW-ON BIOLOGICS, BIOSIMILARS, COSMETIC TAX GENERAL DISCUSSIONS REGARDING ISSUES REALTED TO LUMIGAN AND LATISSE
GENERAL DISCUSSIONS RELATED TO THE SECURITIES AND EXCHANGE COMMISSION'S POLICIES ON FRAUD/INSIDER TRADING
GENERAL ISSUES RELATED TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN, INC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2014 · fourth_quarter · Q4
GENERAL ISSUES RELATED TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN
GENERAL ISSUES RELATED TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2014 · third_quarter · Q3
GENERAL ISSUES RELATED TO TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN
GENERAL ISSUES RELATED TO TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2014 · second_quarter · Q2
GENERAL ISSUES RELATED TO TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN
FOOD AND DRUG ADMINISTRATION (FDA) REGULATION ON RESTASIS DRY DRAFT GUIDANCE GENERAL ISSUES RELATED TO TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2014 · first_quarter · Q1
NO SPECIFIC BILL: FOOD AND DRUG ADMINISTRATION (FDA) DRAFT GUIDANCE ON CYCLOSPORINE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2013 · fourth_quarter · Q4
NO SPECIFIC BILL: TAX REFORM ISSUES
NO SPECIFIC BILL: FOOD AND DRUG ADMINISTRATION (FDA) DRAFT GUIDANCE ON CYCLOSPORINE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2013 · third_quarter · Q3
NO SPECIFIC BILL: ENFORCEMENT OF FOOD AND DRUG ADMINISTRATION (FDA) REGULATIONS NO SPECIFIC BILL: REGULATION OF BIOSIMILAR NEUROMODULATOR PRODUCTS NO SPECIFIC BILL: GOVERNMENT REIMBURSEMENT ISSUES UNDER FEDERAL HEALTHCARE PLANS NO SPECIFIC BILL: FOOD AND DRUG ADMINISTRATION (FDA) DRAFT GUIDANCE REGARDING BIOEQUIVALENCENO SPECIFIC BILL: 340 B DRUG DISCOUNT PROGRAM REFORM NO SPECIFIC BILL: SAFETY ISSUES NO SPECIFIC BILL: TAX REFORM
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2013 · first_quarter · 1A
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2013 · second_quarter · Q2
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2013 · first_quarter · Q1
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2012 · fourth_quarter · 4A
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2012 · third_quarter · 3A
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2012 · second_quarter · 2A
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2012 · first_quarter · 1A
NO SPECIFIC BILL: DISCUSSIONS REGARDING COUNTERFEITS OF LATISSE AND OBESITY ISSUES
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2012 · fourth_quarter · Q4
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2012 · third_quarter · Q3
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2012 · second_quarter · Q2
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE KNOCK-OFFS ISSUE
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2012 · first_quarter · Q1
NO SPECIFIC BILL: DISCUSSIONS REGARDING COUNTERFEITS OF LATISSE AND OBESITY ISSUES
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2011 · fourth_quarter · 4A
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE COUNTERFEITS AND BREAST IMPLANTS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2011 · third_quarter · 3A
NO SPECIFIC BILL: CONGRESSIONAL SUPPORT OF LATISSE PRODUCT AND DISCUSSIONS REGARDING LATISSE COUNTERFEITS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2011 · second_quarter · 2A
NO SPECIFIC BILL: CONGRESSIONAL SUPPORT OF LATISSE PRODUCT AND DISCUSSIONS REGARDING LATISSE COUNTERFEITS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2011 · first_quarter · 1A
NO SPECIFIC BILL: CONGRESSIONAL SUPPORT OF LATISSE PRODUCT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2011 · fourth_quarter · Q4
NO SPECIFIC BILL: DISCUSSIONS REGARDING LATISSE COUNTERFEITS AND BREAST IMPLANTS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2011 · third_quarter · Q3
NO SPECIFIC BILL: CONGRESSIONAL SUPPORT OF LATISSE PRODUCT AND DISCUSSIONS REGARDING LATISSE COUNTERFEITS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2011 · second_quarter · Q2
NO SPECIFIC BILL: CONGRESSIONAL SUPPORT OF LATISSE PRODUCT AND DISCUSSIONS REGARDING LATISSE COUNTERFEITS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2011 · first_quarter · Q1
NO SPECIFIC BILL: CONGRESSIONAL SUPPORT OF LATISSE PRODUCT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · fourth_quarter · 4A
NO SPECIFIC BILL: CONGRESSIONAL AND FOOD AND DRUG ADMINISTRATION SUPPORT OF LATISSE PRODUCT
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · third_quarter · 3A
NO SPECIFIC BILL: LOBBIED CONGRESS TO CONTACT FOOD AND DRUG ADMINISTRATION REGARDING PRODUCT APPROVAL VIOLATIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · second_quarter · 2A
NO SPECIFIC BILL: LOBBIED CONGRESS TO CONTACT FOOD AND DRUG ADMINISTRATION REGARDING PRODUCT APPROVAL VIOLATIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · first_quarter · 1A
HR 3590: PATIENT PROTECTION AND AFFORDABLE CARE ACT; PROVISIONS RELATED TO BIO SIMILARS, FEES AND TAXES
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · third_quarter · 3A
NO SPECIFIC BILL: LOBBIED CONGRESS TO CONTACT FOOD AND DRUG ADMINISTRATION REGARDING PRODUCT APPROVAL VIOLATIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · second_quarter · 2A
NO SPECIFIC BILL: LOBBIED CONGRESS TO CONTACT FOOD AND DRUG ADMINISTRATION REGARDING PRODUCT APPROVAL VIOLATIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · fourth_quarter · Q4
NO SPECIFIC BILL: CONGRESSIONAL AND FOOD AND DRUG ADMINISTRATION SUPPORT OF LATISSE PRODUCT
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · third_quarter · Q3
NO SPECIFIC BILL: LOBBIED CONGRESS TO CONTACT FOOD AND DRUG ADMINISTRATION REGARDING PRODUCT APPROVAL VIOLATIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · second_quarter · Q2
NO SPECIFIC BILL: LOBBIED CONGRESS TO CONTACT FOOD AND DRUG ADMINISTRATION REGARDING PRODUCT APPROVAL VIOLATIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2010 · first_quarter · Q1
HR 3590: PATIENT PROTECTION AND AFFORDABLE CARE ACT; PROVISIONS RELATED TO BIO SIMILARS, FEES AND TAXES
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2009 · fourth_quarter · Q4
HR 3200/S.1796: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009/AMERICA'S HEALTHY FUTURE ACT OF 2009; ISSUES RELATED TO FOLLOW-ON BIOLOGICS, BIOSIMILARS, COSMETIC TAX GENERAL DISCUSSIONS REGARDING ISSUES REALTED TO LUMIGAN AND LATISSE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2009 · third_quarter · 3A
HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; ISSUES RELATED TO FOLLOW-ON BIOLOGICS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2009 · third_quarter · Q3
HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; ISSUES RELATED TO FOLLOW-ON BIOLOGICS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE